Treatment of PAF With the Synaptic System

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 128 participants.

Also called NCT05905835

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 128 participants (enrolled count) (from the registry)
Sponsor
Synaptic Medical Corporation (from the registry)
Registry
  • NCT NCT05905835
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05905835. Allocation not applicable; no masking; primary purpose treatment. Start 2023-09-20 (actual); primary completion 2025-11-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Treatment of PAF With the Synaptic System
Acronym
Sensation
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
Synaptic Cryoablation System
Lead sponsor
Synaptic Medical Corporation (class: industry)

Record details

Record id
cardio:ct-nct05905835
Content hash
ecedc5fb7b15af7311d160edd0102c865769f16b714e05c14f71264c271c4bbe